Cargando…
A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety
Background and study aims Oral sulphate solution (OSS) is a sulphate-based, low-volume bowel cleansing preparation taken in two doses of 500 mL, each followed by 1000mL of water or clear liquid. The primary objective of this observational study was to document compliance with the recommended hydrat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055619/ https://www.ncbi.nlm.nih.gov/pubmed/32140554 http://dx.doi.org/10.1055/a-1090-7289 |
_version_ | 1783503394942484480 |
---|---|
author | Regula, Jaroslaw Spaander, Manon C.W. Suchanek, Stepan Kornowski, Anne Perrot, Valerie Fischbach, Wolfgang |
author_facet | Regula, Jaroslaw Spaander, Manon C.W. Suchanek, Stepan Kornowski, Anne Perrot, Valerie Fischbach, Wolfgang |
author_sort | Regula, Jaroslaw |
collection | PubMed |
description | Background and study aims Oral sulphate solution (OSS) is a sulphate-based, low-volume bowel cleansing preparation taken in two doses of 500 mL, each followed by 1000mL of water or clear liquid. The primary objective of this observational study was to document compliance with the recommended hydration guidelines in a representative sample of the European population. Patients and methods Prospective, non-interventional, multicentre study (NCT02630680, EUPAS9361) in patients prescribed OSS for colonoscopy preparation in routine clinical practice in Europe. Patients were included according to pre-agreed consecutive enrolment rules. Patients recorded the volume of OSS and water or clear liquid intake, and occurrence of adverse events (AEs). Compliance with hydration was calculated as a ratio of actual volume of water/clear liquid taken versus prescribed 2,000 mL, and non-compliance defined as < 75 % intake. Colon cleansing level was assessed on a 4-point scale. Results Between October 2015 and January 2017, 1,281 patients were recruited in 16 centres in four European countries (safety population n = 1,206; registry population n = 1,177). Of patients, 94.5 % were ≥ 75 % and 86.8 % 100 % compliant with hydration guidelines. Patients took an average of 96.8 % of the recommended OSS volume; 46 patients (3.9 %) were non-compliant. Colon cleansing levels were good-to-excellent in 87.6 % of patients. Three hundred and twenty-nine patients (27.3 %) experienced 758 treatment-related AEs, mostly gastrointestinal (82.9 %), all were mild-to-moderate. Non-compliant patients had no AEs suggestive of dehydration. Conclusion In this non-interventional study in a real-life setting, treatment compliance with hydration guidelines was good-to-excellent in 94.5 % of patients receiving OSS. The safety profile of OSS was similar to the prescribing information. TRIAL REGISTRATION: Observational study EUPAS9361 at www.encepp.eu |
format | Online Article Text |
id | pubmed-7055619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | © Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-70556192020-03-05 A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety Regula, Jaroslaw Spaander, Manon C.W. Suchanek, Stepan Kornowski, Anne Perrot, Valerie Fischbach, Wolfgang Endosc Int Open Background and study aims Oral sulphate solution (OSS) is a sulphate-based, low-volume bowel cleansing preparation taken in two doses of 500 mL, each followed by 1000mL of water or clear liquid. The primary objective of this observational study was to document compliance with the recommended hydration guidelines in a representative sample of the European population. Patients and methods Prospective, non-interventional, multicentre study (NCT02630680, EUPAS9361) in patients prescribed OSS for colonoscopy preparation in routine clinical practice in Europe. Patients were included according to pre-agreed consecutive enrolment rules. Patients recorded the volume of OSS and water or clear liquid intake, and occurrence of adverse events (AEs). Compliance with hydration was calculated as a ratio of actual volume of water/clear liquid taken versus prescribed 2,000 mL, and non-compliance defined as < 75 % intake. Colon cleansing level was assessed on a 4-point scale. Results Between October 2015 and January 2017, 1,281 patients were recruited in 16 centres in four European countries (safety population n = 1,206; registry population n = 1,177). Of patients, 94.5 % were ≥ 75 % and 86.8 % 100 % compliant with hydration guidelines. Patients took an average of 96.8 % of the recommended OSS volume; 46 patients (3.9 %) were non-compliant. Colon cleansing levels were good-to-excellent in 87.6 % of patients. Three hundred and twenty-nine patients (27.3 %) experienced 758 treatment-related AEs, mostly gastrointestinal (82.9 %), all were mild-to-moderate. Non-compliant patients had no AEs suggestive of dehydration. Conclusion In this non-interventional study in a real-life setting, treatment compliance with hydration guidelines was good-to-excellent in 94.5 % of patients receiving OSS. The safety profile of OSS was similar to the prescribing information. TRIAL REGISTRATION: Observational study EUPAS9361 at www.encepp.eu © Georg Thieme Verlag KG 2020-03 2020-02-21 /pmc/articles/PMC7055619/ /pubmed/32140554 http://dx.doi.org/10.1055/a-1090-7289 Text en https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Regula, Jaroslaw Spaander, Manon C.W. Suchanek, Stepan Kornowski, Anne Perrot, Valerie Fischbach, Wolfgang A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety |
title | A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety |
title_full | A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety |
title_fullStr | A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety |
title_full_unstemmed | A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety |
title_short | A European, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety |
title_sort | european, multicentre, observational, post-authorisation safety study of oral sulphate solution: compliance and safety |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055619/ https://www.ncbi.nlm.nih.gov/pubmed/32140554 http://dx.doi.org/10.1055/a-1090-7289 |
work_keys_str_mv | AT regulajaroslaw aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT spaandermanoncw aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT suchanekstepan aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT kornowskianne aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT perrotvalerie aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT fischbachwolfgang aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT aeuropeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT regulajaroslaw europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT spaandermanoncw europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT suchanekstepan europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT kornowskianne europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT perrotvalerie europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT fischbachwolfgang europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety AT europeanmulticentreobservationalpostauthorisationsafetystudyoforalsulphatesolutioncomplianceandsafety |